Therefore, the measurement of cumulative IgE levels with a screening test comprising respiratory allergens (i.e., PhadiatopTM) seems superior to the measurement of total IgE levels and classical hypothesis-driven methods for allergy diagnosis for identifying patients with severe allergic asthma and can enhance the clinical efficacy of IgE-targeted asthma therapy. This evidence concerns the gene IGHE and allergic disease.